Skip to main content

NextCure, Inc. (NXTC)

NASDAQ: NXTC · IEX Real-Time Price · USD
7.69
-0.04 (-0.52%)
After-hours:Oct 26, 2021 4:50 PM EDT
7.73
-0.25 (-3.13%)
At close: Oct 26, 4:00 PM

Total Valuation

NextCure has a market cap or net worth of $213.44 million. The enterprise value is -$35.15 million.

Market Cap213.44M
Enterprise Value-35.15M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

NextCure has 27.61 million shares outstanding. The number of shares has increased by 0.34% in one year.

Shares Outstanding27.61M
Shares Change (YoY)+0.34%
Shares Change (QoQ)+0.05%
Owned by Insiders (%)13.45%
Owned by Institutions (%)63.73%
Float17.53M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ratio0.81
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.

EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 30.20, with a Debt / Equity ratio of 0.01.

Current Ratio30.20
Quick Ratio29.33
Debt / Equity0.01
Debt / EBITDA-0.04
Debt / FCF-0.05

Financial Efficiency

Return on Equity (ROE)-23.20%
Return on Assets (ROA)-22.30%
Return on Capital (ROIC)-25.60%
Revenue Per Employeen/a
Profits Per Employee-$737,200
Employee Count90
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -35.80% in the last 52 weeks. The beta is -0.37, so NextCure's price volatility has been lower than the market average.

Beta (1Y)-0.37
52-Week Price Change-35.80%
50-Day Moving Average7.61
200-Day Moving Average7.85
Average Volume (30 Days)302,596

Short Selling Information

Short Interest784,690
Short % of Shares Out2.84%
Short % of Float4.48%
Short Ratio (days to cover)5.51

Income Statement

Revenuen/a
Gross Profitn/a
Operating Income-68.82M
Net Income-66.35M
EBITDA-61.48M
EBIT-66.35M
Earnings Per Share (EPS)-$2.41
Full Income Statement

Balance Sheet

The company has $251.23 million in cash and $2.64 million in debt, giving a net cash position of $248.59 million or $9.00 per share.

Cash & Cash Equivalents251.23M
Total Debt2.64M
Net Cash248.59M
Net Cash Per Share$9.00
Book Value263.60M
Book Value Per Share9.55
Working Capital250.07M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$53.08 million and capital expenditures -$3.83 million, giving a free cash flow of -$56.92 million.

Operating Cash Flow-53.08M
Capital Expenditures-3.83M
Free Cash Flow-56.92M
FCF Per Share-$2.06
Full Cash Flow Statement

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

NextCure does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-31.09%
FCF Yield-26.67%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a